Summary
Aplastic anaemia and agranulocytosis are uncommon but serious adverse effects of drug therapy. They result from an adverse interaction between the drug and the haemopoietic pathway in certain susceptible individuals. The nature of this idiosyncratic interaction differs for diffefent drugs and possibly for different individuals. In some instances an immune mechanism might be implicated, in others the patient’s cells might carry a genetic susceptibility to the drug, while yet other patients might metabolise the drug abnormally. The idiosyncratic nature of these effects has made their investigation difficult, but experimental studies have allowed some progress in our understanding. In a practical sense, however, responsibility for preventing these problems will remain with clinicians, who should be alert to the risks and revise their prescribing habits accordingly.
Similar content being viewed by others
References
Alter BP, Potter NU, Li FP. Classification and aetiology of the aplastic anaemias. Clinics in Haematology 7: 431–465, 1978
Arneborn P, Palmblad J. Drug induced neutropenia in the Stockholm region 1976–77. Acta Medica Scandinavica 206: 241–243, 1979
Australian Drug Evaluation Committee: report of suspected adverse drug reactions, No. 5, Australian Government Publishing Service, Canberrs 1981
Barrett AJ, Faille A, Balitrand N, Ketels F, Najean Y. Bone marrow culture in aplastic anaemia. Journal of Clinical Pathology 32: 660–665, 1979
Baumelou E, Najean Y. Why still prescribe chloramphenicol in 1983? Comparison of the clinical and biological hematologic effects of chloramphenicol and thiamphenicol. Blut 47: 317–320, 1983
Bilezikian SB, Laleli Y, Tsan MF, Hodkinson BA, Ice S, et al. Immunological reactions involving leukocytes: III. agranulocytosis induced by antithyroid drugs. Johns Hopkins Medical Journal 138: 124–129, 1976
Boggs DR, Boggs SS. The pathogenesis of aplastic anemia: A defective pluripotent hematopoietic stem cell with inappropriate balance of differentiation and self-replication. Blood 48: 71–76, 1976
Böttinger LE, Furhoff AK, Holmberg L. Drug-induced blood dycrasias. Acta Medica Scandinavica 205: 457–461, 1979
Böyum A, Lövhaug D, Boecker WR. Regulation of bone marrow cell growth in difusion chambers. The effect of adding normal and leukemic (CML) polymorphonuclear granulocytes. Blood 48: 373–383, 1976
Böyum A, Lövhaug D, Viken KE, Kristiansen T. Medium conditioned for 24 hours by mononuclear human blood cells contains an inducer of granulopoiesis lacking colony stimulating activity. Scandinavian Journal of Haematology 25: 385–393, 1980
Brimblecombe RW, Duncan WAM, Durant GJ, Emmett JC, Ganellin CR, et al. Characterisation and development of Cimetidine as a histamine H2 receptor antagonist. Gastroenterology 74: 339–347, 1978
Broxmeyer HE, Moore MAS, Ralph P. Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils. Experimental Hematology 5: 87–102, 1977
Byron JW. Evidence for the association of a histamine H2 receptor with the haematopoietic stem cell. Pharmacologist 18: 217, 1976
Camitta BM, Storb R, Thomas ED. Aplastic anemia. Pathogenesis, diagnosis, treatment and prognosis. New England Journal of Medicine 306: 645–652, 712-718, 1982
Chikkappa G, Carsten AL, Cronkite EP. Kinetics of proliferation and differentiation of human hemopoietic cells in a diffusion chamber system. Experimental Hematology 5: 533–540, 1980
Cline MJ, Golde DW. Controlling the production of blood cells. Blood 53: 157–165, 1979
Cronkite EP. Erythropoietic cell proliferation in man. Medicine 43: 635–637, 1979
Cronkite EP, Vincent PC. Granulocytopoiesis. Series Haemato-logica 4(II): 3–43, 1969
Cronkite EP, Burlington H, Chanan AD, Joel DD, Reincke U, et al. Concepts and observations on the regulation of granulocyte production. In Baum & Ledney (Eds) Experimental hematology today, pp. 41–49, Springer-Verlag, New York, 1977
Cunningham JL, Leyland MJ, Delamore IW, Price Evans DA. Acetanilide oxidation in phenylbutazone-associted hypoplastic anaemia. British Medical Journal 3: 313–317, 1974
Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. Journal of Cell Physiology 91: 335–344, 1977
Eisner EV, Carr RM, Mackinney AA. Quinidine-induced agranulocytosis. Journal of the American Medical Association 238: 884–886, 1977
Firkin FC, Sumner MA, Bradley TR. The influence of chloramphenicol on the bone marrow haemopoietic stem cell compartment. Experimental Hematology 2: 264–268, 1974
Firkin FC, Moore MAS. Atypical phenylbutazone sensitivity of marrow colony forming units in phenylbutazone-induced aplastic anaemia. In Hibino, Takaku and Shahidi (Eds) Aplastic anemia. Proceedings of the First International Symposium on Aplastic Anemia, September 3–4, 1976, Kyoto, pp. 335–342, University of Tokyo Press, Tokyo, 1976
Freston JW. Cimetidine and granulocytopenia. Annals of internal medicine 90: 264–265, 1979
Fried W. Progress in erythropoiesis and megakaryocytopoiesis. In Baum and Ledney (Eds) Experimental hematology today, pp. 75–77, Springer-Verlag, New York, 1979
Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proceeding of the National Academy of Sciences 77: 4756–4759, 1980
Gordon MY. Relevance of colony forming assays to bone marrow transplantation with particular reference to grafting for aplastic anaemia. British Journal of Haematology 42: 61–71, 1979
Haak HL. Experimental drug-induced aplastic anaemia. Clinics in Haematology 9: 621–639, 1980
Hara H, Kai S, Fushimi M, Taniwaki S, Okamoto T, et al. Pluripotent hemopoietic precursors in vitro (CFUmix) in aplastic anemia. Experimental Hematology 8: 1165–1171, 1980
Heimpel H, Heit W. Drug-induced aplastic anaemia: clinical aspects. Clinics in Haematology 9: 641–662, 1980
Heit W, Kern P, Heimpel H, Kubanek, B. Granulocytic colony forming cells in vitro: 1. Patients with drug induced agranulocytosis. Blut 34: 403–405, 1977
Hoppin EC, Greenberg BR, Walter RM. Agranulocytosis secondary to pentazocine therapy. Archives of Internal Medicine 138: 533–534, 1978
Howell A, Andrews TM, Watts RWE. Bone marrow cells resistant to chloramphenicol-induced aplastic anaemia. Lancet 1: 65–69, 1975a
Howell A, Gumpel JM, Watts RWE. Depression of bone marrow colony formation in gold-induced neutropenia. British Medical Journal 1: 432–434, 1975b
Kaneko S, Motomura S, Ibayashi H. Differentiation of human bone marrow-derived fibroblastoid colony forming cells (CFU-F) and their roles in haemopoiesis in vitro. British Journal of Haematology 51: 217–225, 1982
Kelton JG, Huang AT, Mold N, Logue G, Rosse WF. The use of in vitro technics to study drug-induced pancytopenia. New England Journal of Medicine 301: 621–624, 1979
Kern P, Heimpel H, Heit W, Kubanek B. Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced aplastic anaemia. Lancet 1: 1190, 1975
Kern P, Heimpel, H, Heit W, Kubanek B. Granulocytic progenitor cells in aplastic anaemia. British Journal of Haematology 35: 613–623, 1977
Klassen LW, Birks J, Allen E, Gurney CW. Experimental medullary aplasia. Journal of Laboratory and Clinical Medicine 80: 8–17, 1972
Knospe WH, Crosby WH. Aplastic anaemia: a disorder of the bone-marrow sinusoidal microcirculation rather than stem-cell failure? Lancet 1: 20–22, 1971
Kurland J, Moore MAS. The regulatory role of the macrophage in normal and neoplastic hemopoiesis. In Baum & Ledney (Eds) Experimental hematology today, pp. 51–64, Springer-Verlag, New York, 1977
Lajtha LG. Haemopoietic stem cells. British Journal of Haematology 29: 529–535, 1975
Lind DE, Levi JA, Vincent PC. Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro. British Medical Journal 1: 458–460, 1973
Lord BI. Proliferation regulators in haemopoiesis. Clinics in Haematology 8: 435–451, 1979
Mangan KF, Desforges JF. The role of T-lymphocytes and monocytes in the regulation of human erythropoietic peripheral blood burst forming units. Experimental Hematology 8: 717–727, 1980
Messner HA, Fauser AA. Culture studies of human pluripotent hemopoietic progenitors. Blut 41: 327–333, 1980
Metcalf D, Merchav S, Wagemaker G. Commitment by GM-CSF or M-CSF of bipotential GM progenitor cells to granulocyte or macrophage formation. In Baum, Ledney and Thierfelder (Eds) Experimental Hematology Today, pp. 3–9, S. Karger, Basel, 1982
Moeschlin S, Wagner K. Agranulocytosis due to the occurrence of leucocyte-agglutinins. Acta Haematologica 8: 29–41, 1952
Morley A. Residual marrow damage from cytotoxic drugs. Australian and New Zealand Journal of Medicine 10: 569–571, 1980
Morley A, Blake J. Haemopoietic precursor cells in experimental hypoplastic marrow failure. Australian Journal of Experimental Biology and Medical Science 52: 909–914, 1974
Morley A, Furness M, Higgs D. Inhibition of growth of marrow cells by chloramphenicol. Australian Journal of Experimental Biology and Medical Science 52: 847–850, 1974
Morley A, Trainor K, Blake J. A primary stem cell lesion in experimental chronic hypoplastic marrow failure. Blood 45: 681–688, 1975
Morley A, Trainor K, Remes J. Residual Imarrow damage: possible explanation for idiosyncrasy to chloramphenicol. British Journal of Haematology 32: 525–531, 1976
Morley A, Trainor K, Seshadri RS. Chronic hypoplastic marrow failure and residual injury. Blood Cells 4: 253–266, 1978
Morris TCM, Vincent PC, Sutherland R, Hersey P. Inhibition of normal human granulopoiesis in vitro by non-B non-T lymphocytes. British Journal of Haematology 45: 541–550, 1980
Morris TCM, Vincent PC, Young GAR, Sutherland R, Forrest PR, et al. CUF-C inhibitors in aplastic anaemia. Blut 48: 1–14, 1984
Nagao T, Mauer AM. Concordance for drug-induced aplastic anemia in identical twins. New England Journal of Medicine 281: 7–11, 1969
Nieweg HO. Aplastic anemia (panmyelopathy). In Girdwood (Ed.) Blood disorders due to drugs and other agents, pp. 84–106, Excerpta Medica, Amsterdam, 1974
Pelus LM, Broxmeyer HE, Kurland JI, Moore MAS. Regulation of macrophage and granulocyte proliferation. Journal of Experimental Medicine 150: 277–292, 1979
Petz LD, Fudenberg HH. Immunologic mechanisms in drug-induced cytopenias. Progress in Hematology 9: 185–206, 1975
Pisciotta AV. Immune and toxic mechanisms in drug-induced agranulocytosis. Seminars in Hematology 10: 279–310, 1973
Ratzan R, Moore MAS, Yunis AA. Effect of chloramphenicol and thiamphenicol on the in vitro colony-forming cell. Blood 43: 363–369, 1974
Samsom JP, Hulstaert CE, Molenaar I, Nieweg HO. Fine structure of the bone marrow sinusoidal wall in idiopathic and drug-induced panmyelopathy. Acta Haematologica 48: 218–226, 1972
Singer JW, Brown JE. In vitro marrow culture techniques in aplastic anaemia and related disorders. Clinics in Haematology 7: 487–499, 1978
Smith CS, Chinn S, Watts RWE. The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia. Biochemical Pharmacology 26: 847–852, 1977
Stohlman F, Ebbe S, Morse B, Howard D, Donovan J. Regulation of erythropoiesis XX kinetics of red cell production. Annals of the New York Academy of Sciences 149: 156–172, 1968
Strieker BH, Oei TT. Agranulocytosis caused by spironolactone. British Medical Journal 289: 731, 1984
Sutherland R, Vincent PC, Raik E, Burgess K. Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro. British Medical Journal 1: 605–607, 1977
Taetle R, Lane TA, Mendelsohn J. Drug-induced agranulocytosis: in vitro evidence for immune suppression of granulopoiesis and a cross-reacting lymphocyte antibody. Blood 54: 501–512, 1979
Till JE, McCulloch EA, Siminovitch L. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proceeding of the National Academy of Sciences 51: 29–36, 1964
Trainor KJ, Seshadri RS, Morley AA. Residual marrow injury following cytotoxic drugs. Leukemia Research 3: 205–210, 1979
Trainor KJ, Morley AA, Seshadri RS. A proliferative defect of marrow cells in experimental chronic hypoplastic marrow failure (aplastic anaemia). Experimental Hematology 8: 674–682, 1980
Tso SC, Chan TK, Todd D. Aplastic anaemia: a study of prognosis and the effect of androgen therapy. Quarterly Journal of Medicine 46: 513–529, 1977
Vincent PC, De Gruchy GC. Complications and treatment of acquired aplastic anaemia. British Journal of Haematology 13: 977–999, 1967
Vincent PC. Granulocyte kinetics in health and disease. Clinics in Haematology 6: 695–717, 1977
Vincent PC. In vitro evidence of drug action in aplastic anemia. Blut 49: 3–12, 1984
Weisberger AS, Wolfe S, Armentrout S. Inhibition of protein synthesis in mammalian cell-free systems of chloramphenicol. Journal of Experimental Medicine 120: 161–181, 1964
Weitzman SA, Stossel TP, Desmond M. Drug-induced immunological neutropenia. Lancet 1: 1068–1072, 1978
Williams N, Jackson H, Rabellino EM. Proliferation and differentiation of normal granulopoietic cells in continuous bone marrow cultures. Journal of Cellular Physiology 93: 435–440, 1977
Williams DM, Lynch RE, Cartwright GE. Drug-induced aplastic anemia. Seminars in Hematology 10: 195–223, 1973
Williams WJ, Beutler E, Erslev AJ, Lichtman MA. Hematology, 3rd ed, McGraw-Hill, New York, 1983
Yataganas X, Gahrton G, Thorell B. DNA, RNA and hemoglobin during erythroblast maturation. Experimental Cell Research 62: 254–261, 1970
Young GAR. Drug-induced haematological disorders. Current Therapeutics 25 (No. 8): 61–69, 1984
Young GAR, Croaker G, Joyce RM, Forrest P, Vincent PC. In preparation, 1984
Young GAR, Forrest P, Deveridge SF, Gates RB, Vincent PC. Mebhydrolin induced agranulocytosis. Australian and New Zealand Journal of Medicine 12: 173–176, 1982
Young GAR, Vincent PC. Drug-induced agranulocytosis. Clinics in Haematology 9: 483–504, 1980
Yunis AA. Chloramphenicol-induced bone marrow suppression. Seminars in Hematology 10: 225–234, 1973
Yunis AA. Chloramphenicol toxicity. In Girdwood (Ed.) Blood disorders due to drugs and other agents, pp. 107–126, Excerpta Medica, 1974
Yunis AA, Adamson JW. Differential in vitro sensitivity of marrow erythroid and granulocytic colony forming cells to chloramphenicol American Journal of Hematology 2: 355–363, 1977
Yunis AA, Miller AM, Salem Z, Arimura GK. Chloramphenicol toxicity: pathogenetic mechanisms and the role of the p-No2 in aplastic anemia. Clinical Toxicology 17: 359–373, 1980
Zelkowitz L, Arimura GK, Yunis AA. Chloramphenicol and protein synthesis in mammalian cells. Journal of Laboratory and Clinical Medicine 71: 596–609, 1968
Zipori D, Sasson T, Friedman S. Bone marrow resident colony-stimulating factor activity (CSA) produced by stromal cells: In Baum et al. (Eds) Experimental hematology today, pp. 19–26, S. Karger, Basel, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vincent, P.C. Drug-Induced Aplastic Anaemia and Agranulocytosis. Drugs 31, 52–63 (1986). https://doi.org/10.2165/00003495-198631010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198631010-00004